home / stock / phio / phio news

PHIO News and Press, Phio Pharmaceuticals Corp. From 01/31/24

Stock Information
Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com
Menu
PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...
PHIO - Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies

-- New preclinical data to be presented at Immunotherapy Conference in Germany MARLBOROUGH, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is desig...
PHIO - Phio Pharmaceuticals files to sell 4.42M shares of common stock for holders

2023-12-19 17:07:29 ET More on Phio Pharmaceuticals Seeking Alpha’s Quant Rating on Phio Pharmaceuticals Historical earnings data for Phio Pharmaceuticals Financial information for Phio Pharmaceuticals For further details see: Phio Pharmaceuticals ...

PHIO - RKDA, SATL and CYN among mid-day movers

2023-12-07 12:33:24 ET More on Mid-day movers & stocks. Arcadia Biosciences, Inc. (RKDA) Q3 2023 Earnings Call Transcript Satellogic: Shrinking Satellite Network And Revenues Below Forecasts Again Cyngn raises $1.3M under ATM sales agreement to expand its revenue...

PHIO - Organovo, Fortress Biotech among healthcare movers

2023-12-07 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Organovo, Fort...
PHIO - BYU, ABLV and LGHL among pre-market losers

2023-12-07 08:32:42 ET Losers: Troika Media Group TRKA -71% announces chapter 11 filing and sale to Blue Torch . Phio Pharmaceuticals Corp ( PHIO ) -48% announces exercise of warrants for $2.8 Million gross proceeds . ZyVersa Therapeutics ZVSA -46% on ...

PHIO - Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds

MARLBOROUGH, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced the agreement ...

PHIO - Micro Surprise- 24/7 Market News Daily Wrap 6 Dec 2023

2023-12-06 17:29:59 ET DENVER, Colo., Dec. 6, 2023 ( www.247marketnews.com )- The following companies published announcements or traded higher-than-usual volume; Sera Prognostics Inc (NASDAQ: SERA), MicroAlgo Inc (NASDAQ: MLGO), Syros Pharmaceuticals Inc (NASDAQ: SYRS), Altimmune Inc (N...
PHIO - ALT, SYRS and PHIO among mid-day movers

2023-12-06 12:41:58 ET More on Mid-day movers $ stocks. Altimmune: Don't Buy The GLP-1 Move-Up Altimmune: Pemvidutide Data Reinforces Obesity Drug Outlook Syros Pharmaceuticals, Inc. (SYRS) Q3 2023 Earnings Call Transcript Altimmune weight-loss drug performed...

PHIO - Muy Verde- 24/7 Market News Lunch Break 6 Dec 2023

2023-12-06 12:33:41 ET DENVER, Colo., Dec. 6, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Sera Prognostics Inc (NASDAQ: SERA), MicroAlgo Inc (NASDAQ: MLGO), Kamada Ltd (NASDAQ: KMDA), Syros Pha...

PHIO - TGTX, IBIO and ALT are among pre market gainers

2023-12-06 08:32:51 ET MicroAlgo ( MLGO ) +57% announced plans to establish a practice base to train graduate students for the university Pharvaris ( PHVS ) +38% surges on mid-stage success for hereditary angioedema therapy. ZyVersa Therapeutics  ( ZVSA ...
Previous 10 Next 10